Pellucid Marginal Corneal Degeneration

Explore clinical trials studying Pellucid Marginal Corneal Degeneration. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Pellucid Marginal Corneal Degeneration trial results

Recruiting

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

NCT07124910

Conditions: Corneal Diseases, Ectasia of Cornea, Eye Diseases, +3 more
Locations: Woolfson Eye Institute Atlanta, Georgia, United States

Woolfson Eye Institute Atlanta, Georgia, United States

Woolfson Eye Institute Canton, Georgia, United States

Woolfson Eye Institute Cumming, Georgia, United States

View Trial Details

Recruiting

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

NCT04094090

Conditions: Corneal Diseases, Corneal Ectasia, Eye Diseases, +2 more
Locations: Goodman Eye Center San Francisco, California, United States

View Trial Details

Completed

Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

NCT04667572

Conditions: Corneal Degeneration, Corneal Diseases, Corneal Ectasia, +3 more
Locations: Cornea Associates of Texas Dallas, Texas, United States

View Trial Details

Completed

Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting

NCT04649177

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +36 more
Locations: BostonSight Needham, Massachusetts, United States

View Trial Details

Completed

Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

NCT04177082

Conditions: Corneal Degeneration, Corneal Diseases, Corneal Ectasia, +3 more
Locations: Cornea Associates of Texas Dallas, Texas, United States

View Trial Details

Completed

A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea

NCT03220529

Conditions: Corneal Diseases, Eye Diseases, Keratectasia, +2 more
Locations: Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States

Institute for Refractive and Ophthalmic Surgery Zurich, Switzerland

View Trial Details

Completed

Scleral Versus Corneal RGP Contact Lenses in Irregular Cornea Disorders

NCT02444923

Conditions: Corneal Diseases, Corneal Injuries, Craniocerebral Trauma, +11 more
Locations: Central Middlesex Hospital London, United Kingdom

View Trial Details

Pellucid Marginal Corneal Degeneration

Pellucid Marginal Corneal Degeneration trial results

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting

Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea

Scleral Versus Corneal RGP Contact Lenses in Irregular Cornea Disorders

Related conditions